Loading patent…
AssigneeMillennium Pharmaceuticals, Inc.
InventorInmaculada Silos-Santiago
Estimating the term…
The present invention relates to methods for the diagnosis and treatment of pain or painful disorders. Specifically, the present invention identifies the differential expression of 577, 20739 OR 57145 genes in tissues relating to pain sensation, relative to their expression in normal, or non-painful disease states, and/or in response to manipulations relevant to pain. The present invention describes methods for the diagnostic evaluation and prognosis of various cardiovascular diseases, and for the identification of subjects exhibiting a predisposition to such conditions. The invention also provides methods for identifying a compound capable of modulating pain or painful disorders. The present invention also provides methods for the identification and therapeutic use of compounds as treatments of pain and painful disorders.
A method for identifying a compound capable of treating a pain disorder, comprising assaying the ability of the compound to modulate 577, 20739 OR 57145 nucleic acid expression or 577, 20739 OR 57145 polypeptide activity, thereby identifying a compound capable of treating a pain disorder.
A method for identifying a compound capable of modulating a pain signaling mechanism comprising:
A method for modulating a pain signaling mechanism in a cell comprising contacting a cell with a 577, 20739 OR 57145 modulator, thereby modulating a pain signaling mechanism in the cell.
A method for treating a subject having a pain disorder characterized by aberrant 577, 20739 OR 57145 polypeptide activity or aberrant 577, 20739 OR 57145 nucleic acid expression comprising administering to the subject a 577, 20739 OR 57145 modulator, thereby treating said subject having a pain disorder.
Dependencies are inferred from the claim text.